ESCITALOPRAM OXALAT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7861 for the supply of ESCITALOPRAM OXALAT, identified by NSN 6505017183484 and PR 7017575511, with a total contract value of $51.70. The award was issued on July 21, 2026, as a delivery order under the parent contract SPE2DX25D9900, and the performance location is within the United States under federal procurement authority. The contract type is classified as a federal award notice, and no specific set-aside or NAICS code is indicated, indicating a standard procurement action without demographic or small business preferences. The awardee, identified by CAGE code 1UNB0, is tasked with fulfilling this order to support Department of Defense medical supply needs, with no additional point of contact details provided in the record.
General Info
Agency
Contract Value
$51.7NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
